Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 2929 Neoplasms 2624 Lung Neoplasms 1366 Colorectal Neoplasms 1328 Prostatic Neoplasms 1214 Carcinoma, Non-Small-Cell Lung 1079 Carcinoma, Hepatocellular 782 Stomach Neoplasms 720 Pancreatic Neoplasms 701 Ovarian Neoplasms 586 Colonic Neoplasms 533 Uterine Cervical Neoplasms 497 Head and Neck Neoplasms 495 Rectal Neoplasms 472 Melanoma 467 Multiple Myeloma 463 Esophageal Neoplasms 422 Neoplasm Metastasis 418 Brain Neoplasms 404 Lymphoma 399 Precursor Cell Lymphoblastic Leukemia-Lymphoma 397 Urinary Bladder Neoplasms 386 Leukemia, Myeloid, Acute 385 Leukemia 339 Carcinoma, Renal Cell 329 Liver Neoplasms 320 Endometrial Neoplasms 319 Hematologic Neoplasms 312 Recurrence 298 Disease 272

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ampullary Adenocarcinoma × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡